Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.830
+0.030 (1.67%)
At close: Sep 15, 2025, 4:00 PM EDT
1.820
-0.010 (-0.52%)
After-hours: Sep 15, 2025, 5:57 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $85.39 million as of September 15, 2025. Its market cap has increased by 36.67% in one year.
Market Cap
85.39M
Enterprise Value
74.28M
1-Year Change
36.67%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $85.39M, an increase of 18.98%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 82.19M | 5.26% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |